SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.
SINGAPORE, March 03, 2023) Novotech research data shows between 2017 and 2021, there were close to 1,400 industry-sponsored single-country vaccine-based clinical trials globally, with the Asia Pacific
Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA TrendsSINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar with Endpoints News covering the evolving landscape i.